With a value of 122.6 billion dollars in 2017, which in 2022 will reach a figure of 145 and 175 billion dollars, the Chinese pharmaceutical market was the second largest in the world, after the US. A huge development that has not gone unnoticed by Alibaba, the Chinese colossus of e-commerce, who last June after […]
PQE Group has been named among the excellent companies of 2018 in Italy according to the research conducted by the Osservatorio PMI carried out by Global Strategy, a strategic and financial consulting firm that presented the results of the tenth edition yesterday at Palazzo Mezzanotte, Stock Exchange Headquarters in Milan. In this tenth edition, 724 […]
PQE earned a righteous spot in the FT 1000 2018 Ranking for the fastest growing companies in Europe.
Published today in the Official Bulletin of the State, the legislative decree number 101/2018 aligns Italy to the GDPR rules that have been released on May 25th. The decree will be active from September 19, 2018 and aims to bring a step forward for the transparency in the relations between patients and health service; as […]
PQE Group is proud to announce that the draft of the new Russian Guide for Industrial Data Integrity has been published on the website of GILS – Russian State Institute of Drugs and Good Practices. After the collaboration with COFEPRIS, the Mexican Regulatory Authority, for the creation of the data integrity chapter of the NOM […]
On Wednesday 27th of June has been presented at the 3rd PDA Europe Annual Meeting in Berlin a white paper about the issue of the Audit Trails Review. The ongoing theme of the European Annual Meeting is Global Healthcare of the Present & the Future, as it intends to continue spanning a bridge between current […]
PQE awarded as one of the fastest growing companies in Italy and Europe
Drug Development and CMC, as well as Product Development
Every year we support two important associations: Help 4 Friends and Rare Partners